These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33788417)

  • 1. Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene.
    Zobeck MC; Bernhardt MB; Kamdar KY; Rabin KR; Lupo PJ; Scheurer ME
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29036. PubMed ID: 33788417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
    Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
    Widemann BC; Hetherington ML; Murphy RF; Balis FM; Adamson PC
    Cancer; 1995 Aug; 76(3):521-6. PubMed ID: 8625136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia.
    Zobeck M; Bernhardt MB; Kamdar KY; Rabin KR; Lupo PJ; Scheurer ME
    Pharmacotherapy; 2023 Mar; 43(3):205-214. PubMed ID: 36764694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
    Widemann BC; Balis FM; Shalabi A; Boron M; O'Brien M; Cole DE; Jayaprakash N; Ivy P; Castle V; Muraszko K; Moertel CL; Trueworthy R; Hermann RC; Moussa A; Hinton S; Reaman G; Poplack D; Adamson PC
    J Natl Cancer Inst; 2004 Oct; 96(20):1557-9. PubMed ID: 15494606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2.
    Adamson PC; Balis FM; McCully CL; Godwin KS; Bacher JD; Walsh TJ; Poplack DG
    J Clin Oncol; 1991 Apr; 9(4):670-4. PubMed ID: 2066764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucarpidase treatment for methotrexate intoxication: a case report and review of the literature.
    Boelens AD; Mathôt RAA; Vlaar APJ; Bouman CSC
    Neth J Med; 2018 Jan; 76(1):36-39. PubMed ID: 29380731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.
    Buchen S; Ngampolo D; Melton RG; Hasan C; Zoubek A; Henze G; Bode U; Fleischhack G
    Br J Cancer; 2005 Feb; 92(3):480-7. PubMed ID: 15668713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
    Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
    Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure].
    von Poblozki A; Dempke W; Schmoll HJ
    Med Klin (Munich); 2000 Aug; 95(8):457-60. PubMed ID: 10985069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
    Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
    J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys.
    Adamson PC; Balis FM; McCully CL; Godwin KS; Poplack DG
    J Clin Oncol; 1992 Aug; 10(8):1359-64. PubMed ID: 1634927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase.
    Taylor ZL; Mizuno T; Punt NC; Baskaran B; Navarro Sainz A; Shuman W; Felicelli N; Vinks AA; Heldrup J; Ramsey LB
    Clin Pharmacol Ther; 2020 Sep; 108(3):635-643. PubMed ID: 32558929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia.
    den Hoed MA; Lopez-Lopez E; te Winkel ML; Tissing W; de Rooij JD; Gutierrez-Camino A; Garcia-Orad A; den Boer E; Pieters R; Pluijm SM; de Jonge R; van den Heuvel-Eibrink MM
    Pharmacogenomics J; 2015 Jun; 15(3):248-54. PubMed ID: 25348617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between polymorphisms of dihydrofolate reductase and gamma glutamyl hydrolase genes and toxicity of high dose methotrexate in children with acute lymphoblastic leukemia.
    Koomdee N; Hongeng S; Apibal S; Pakakasama S
    Asian Pac J Cancer Prev; 2012; 13(7):3461-4. PubMed ID: 22994778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma.
    Truong HL; Barreto JN; Mara KC; Hampel PJ; Micallef IN; Nowakowski GS; Thanarajasingam G; Thompson CA; Wang Y; Witzig TE; Herrmann SM; Leung N
    JCO Oncol Pract; 2024 Jun; 20(6):797-807. PubMed ID: 38408299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
    Heuschkel S; Kretschmann T; Teipel R; von Bonin S; Richter S; Quick S; Alakel N; Röllig C; Balaian E; Kroschinsky F; Knoth H; Bornhäuser M; von Bonin M
    Cancer Chemother Pharmacol; 2022 Jan; 89(1):41-48. PubMed ID: 34669022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia.
    Radtke S; Zolk O; Renner B; Paulides M; Zimmermann M; Möricke A; Stanulla M; Schrappe M; Langer T
    Blood; 2013 Jun; 121(26):5145-53. PubMed ID: 23652803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.
    Widemann BC; Balis FM; Kim A; Boron M; Jayaprakash N; Shalabi A; O'Brien M; Eby M; Cole DE; Murphy RF; Fox E; Ivy P; Adamson PC
    J Clin Oncol; 2010 Sep; 28(25):3979-86. PubMed ID: 20679598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed Methotrexate Clearance Despite Carboxypeptidase-G2 (Glucarpidase) Administration in 2 Patients With Toxic Methotrexate Levels.
    Wyatt KD; Cooper J; Scott K; Broomall E; Altaf S; Hogan MC; Rodriguez V; Khan S
    J Pediatr Hematol Oncol; 2018 Mar; 40(2):152-155. PubMed ID: 29240024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.